Skip to main content
Filing year 2024

New York Metropolitan Breast Cancer Group Inc

Sacramento, California·EIN 51-0198355·501(c)(3)
Total revenue
$136k
Total assets
$443k
Total expenses
$90k
Reported officers
8

Executive compensation

Form 990-EZ · Part IV · 1 reported individual · Filing year 2024

Executive Dir.
Unclassified
$18k
$20k

Teal figures restate each filed amount in 2026 dollars.

Estimated with BLS CPI-U for the West region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 7 unpaid individuals.

Down 5%
from 2022

From $19k in 2022 to $18k in 2024.

$19k
2022
$18k
2024
In today's dollarsEst.
Down 11% in real terms$22k to $20k

Estimated with BLS CPI-U for the West region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.
Financial trend

Revenue and expenses over time

New York Metropolitan Breast Cancer Group Inc reported revenue and expenses across 3 filing years.

RevenueExpenses
$146k
$78k
2022
$144k
$86k
2023
$136k
$90k
2024
Total revenue and total expenses from IRS Form 990 filings.
FAQ

Common questions about New York Metropolitan Breast Cancer Group Inc

What are New York Metropolitan Breast Cancer Group Inc's revenue and expenses?

In 2024, New York Metropolitan Breast Cancer Group Inc reported $136k in total revenue and $90k in total expenses on its IRS Form 990.

Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.